A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.

about

A small-molecule inhibitor of SMAD3 attenuates resistance to anti-HER2 drugs in HER2-positive breast cancer cells.

Item

http://www.wikidata.org/entity/Q48134448

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A small-molecule inhibitor of ...... -positive breast cancer cells.

@en

A small-molecule inhibitor of ...... -positive breast cancer cells.

@nl

type

Item

label

A small-molecule inhibitor of ...... -positive breast cancer cells.

@en

A small-molecule inhibitor of ...... -positive breast cancer cells.

@nl

prefLabel

A small-molecule inhibitor of ...... -positive breast cancer cells.

@en

A small-molecule inhibitor of ...... -positive breast cancer cells.

@nl

P1476

A small-molecule inhibitor of ...... -positive breast cancer cells.

@en

P2093

Ako Ohara

http://www.w3.org/2001/XMLSchema#string

Ami Hori

http://www.w3.org/2001/XMLSchema#string

Atsushi Shimomura

http://www.w3.org/2001/XMLSchema#string

Jun-Ichiro Ikeda

http://www.w3.org/2001/XMLSchema#string

Kenzo Shimazu

http://www.w3.org/2001/XMLSchema#string

Naofumi Kagara

http://www.w3.org/2001/XMLSchema#string

Seung Jin Kim

http://www.w3.org/2001/XMLSchema#string

Shinzaburo Noguchi

http://www.w3.org/2001/XMLSchema#string

Tomonori Tanei

http://www.w3.org/2001/XMLSchema#string

Yasuto Naoi

http://www.w3.org/2001/XMLSchema#string

P2860

Recombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivation

Transforming growth factor beta engages TACE and ErbB3 to activate phosphatidylinositol-3 kinase/Akt in ErbB2-overexpressing breast cancer and desensitizes cells to trastuzumab

Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasis

The epithelial-mesenchymal transition generates cells with properties of stem cells

Prospective identification of tumorigenic breast cancer cells

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

Lapatinib plus capecitabine for HER2-positive advanced breast cancer.

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.

Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts

TGFβ signalling in context

P2888

s10549-017-4382-6

P304

55-68

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-017-4382-6

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

166

http://www.w3.org/2001/XMLSchema#string

P50

Masafumi Shimoda

P577

2017-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28702892

http://www.w3.org/2001/XMLSchema#string